Trident Texofab Hits New 52-Week High of Rs. 340.1 Amid Strong Market Momentum

Trident Texofab, a microcap player in the Garments & Apparels industry, has reached a significant milestone by hitting a new 52-week high of Rs. 340.1 today, October 6, 2025. This achievement marks a notable performance, as the stock has outperformed its sector by 0.33%. Over the past six days, Trident Texofab has demonstrated a strong upward trend, accumulating a remarkable 10.78% return during this period.
The stock opened at Rs. 340.1 and has maintained this price throughout the trading session. Additionally, Trident Texofab is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust market position.

In the broader market context, the Sensex has also shown positive movement, climbing 209.53 points to reach 81,484.32, reflecting a 0.34% increase. The Sensex is now just 3.21% away from its own 52-week high. Overall, Trident Texofab's recent performance underscores its strong position within the market, especially considering its impressive one-year performance of 649.78%, contrasting sharply with the Sensex's decline of 0.21%.